Scholars will continue their innovative work on one of humanity’s oldest and most complex problems – how to ethically ensure enough nutritious food for the world’s population. Read More
A university-wide team will look at the ethical, legal and social implications (ELSI) of applying genomics to research on, and prevention and treatment of, infectious disease. Read More
After 20 years, Ruth R. Faden will step aside from the directorship of the Berman Institute on June 30, 2016, while retaining her faculty position as the Philip Franklin Wagley Professor of Biomedical Ethics, with a full academic portfolio. Read More
Reflections from three public health deans. Featuring Johns Hopkins Bloomberg School of Public Health Dean Michael Klag and Deans Emeritus, Alfred Sommer & D. A. Henderson. These three renowned leaders discuss some of the biggest ethical challenges faced in their professional lives. Moderated by our Nancy Kass.
The Berman Institute will be well represented at the 4th annual conference of the Academy for Professionalism in Health Care (APHC). The meeting will be held April 28-30 in Philadelphia.
Berman Institute scholars are members of a research team that has received funding from the Wellcome Trust to develop guidance for conducting research with pregnant women in the midst of a public health crisis. Read More
Johns Hopkins Experts Examine the Ethics of HIV-Positive Organ Transplants. Read More
Former Greenwall Fellow at the Berman Institute and current professor of law and director of the Center for Law, Health & Society at Georgia State Law, Leslie Wolf, JD, MPH., will become the first inductee to represent the Berman Institute’s fellowship program and lawyers in the Society of Scholars.
Monday, March 28, Noon: Feinstone Hall, Johns Hopkins Bloomberg School of Public Health. The IOM report on Mitochondrial Replacement Techniques released in Feb 2016 includes recommendations to the FDA about the ethical permissibility of first human investigations. IOM committee chair, Professor Jeffrey Kahn, will share the committee’s analysis and his insights on the issues addressed.
(Video) Our expert panel leads a discussion about the challenges associated with the determination of medical decision-making capacity.